Literature DB >> 22977545

Significance of aldehyde dehydrogenase 1 expression in stromal cells of diffuse large B-cell lymphoma.

Shigeki Fujita1, Eiichi Morii, Nur Rahadiani, Naoki Wada, Yumiko Hori, Jun-Ichiro Ikeda, Katsuyuki Aozasa.   

Abstract

Aldehyde dehydrogenase (ALDH) 1 is expressed in various stem/progenitor cells, including cancer-initiating cells (CICs). In the present study, ALDH1 expression was immunohistochemically examined in diffuse large B-cell lymphoma (DLBCL). Unexpectedly, ALDH1 expression was occasionally detected in stromal cells, but not in lymphoma cells. Positively stained cells were CD68(+) cells with voluminous cytoplasm and fascin(+) cells with reticular morphology, designated as macrophages and dendritic cells (DCs), respectively. The presence of ALDH1(+) macrophages was not correlated with stage, response to therapies and prognosis. However, cases with ALDH1(+) DCs were mostly nodal, which showed a poorer response to therapies and a worse overall survival rate than cases without ALDH1(+) DCs. The presence of ALDH1(+) DCs appears to be involved in the malignant potential of DLBCL in lymph node.

Entities:  

Year:  2011        PMID: 22977545      PMCID: PMC3440706          DOI: 10.3892/etm.2011.269

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  19 in total

Review 1.  Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group.

Authors:  B D Cheson; S J Horning; B Coiffier; M A Shipp; R I Fisher; J M Connors; T A Lister; J Vose; A Grillo-López; A Hagenbeek; F Cabanillas; D Klippensten; W Hiddemann; R Castellino; N L Harris; J O Armitage; W Carter; R Hoppe; G P Canellos
Journal:  J Clin Oncol       Date:  1999-04       Impact factor: 44.544

2.  Aldehyde dehydrogenase 1 A1-positive cell population is enriched in tumor-initiating cells and associated with progression of bladder cancer.

Authors:  Yun Su; Qi Qiu; Xingqiao Zhang; Zhengran Jiang; Qixin Leng; Zhenqiu Liu; Sanford A Stass; Feng Jiang
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-02       Impact factor: 4.254

3.  Prognostic significance of tumorigenic cells with mesenchymal features in pancreatic adenocarcinoma.

Authors:  Zeshaan A Rasheed; Jie Yang; Qiuju Wang; Jeanne Kowalski; Irwin Freed; Christopher Murter; Seung-Mo Hong; Jan-Bart Koorstra; N V Rajeshkumar; Xiaobing He; Michael Goggins; Christine Iacobuzio-Donahue; David M Berman; Daniel Laheru; Antonio Jimeno; Manuel Hidalgo; Anirban Maitra; William Matsui
Journal:  J Natl Cancer Inst       Date:  2010-02-17       Impact factor: 13.506

Review 4.  Tumor-stromal cell interactions and opportunities for therapeutic intervention.

Authors:  Taturo Udagawa; Mark Wood
Journal:  Curr Opin Pharmacol       Date:  2010-07-16       Impact factor: 5.547

5.  The M1 form of tumor-associated macrophages in non-small cell lung cancer is positively associated with survival time.

Authors:  Junliang Ma; Lunxu Liu; Guowei Che; Nanbin Yu; Fuqiang Dai; Zongbing You
Journal:  BMC Cancer       Date:  2010-03-25       Impact factor: 4.430

6.  Aldehyde dehydrogenase 1 is a tumor stem cell-associated marker in lung cancer.

Authors:  Feng Jiang; Qi Qiu; Abha Khanna; Nevins W Todd; Janaki Deepak; Lingxiao Xing; Huijun Wang; Zhenqiu Liu; Yun Su; Sanford A Stass; Ruth L Katz
Journal:  Mol Cancer Res       Date:  2009-03-10       Impact factor: 5.852

7.  Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray.

Authors:  Christine P Hans; Dennis D Weisenburger; Timothy C Greiner; Randy D Gascoyne; Jan Delabie; German Ott; H Konrad Müller-Hermelink; Elias Campo; Rita M Braziel; Elaine S Jaffe; Zenggang Pan; Pedro Farinha; Lynette M Smith; Brunangelo Falini; Alison H Banham; Andreas Rosenwald; Louis M Staudt; Joseph M Connors; James O Armitage; Wing C Chan
Journal:  Blood       Date:  2003-09-22       Impact factor: 22.113

8.  Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis.

Authors:  Emina H Huang; Mark J Hynes; Tao Zhang; Christophe Ginestier; Gabriela Dontu; Henry Appelman; Jeremy Z Fields; Max S Wicha; Bruce M Boman
Journal:  Cancer Res       Date:  2009-03-31       Impact factor: 12.701

Review 9.  Treatment resistance in stem cells and breast cancer.

Authors:  Bhuvanesh Dave; Jenny Chang
Journal:  J Mammary Gland Biol Neoplasia       Date:  2009-03-04       Impact factor: 2.673

10.  ALDH1A1 is a marker for malignant prostate stem cells and predictor of prostate cancer patients' outcome.

Authors:  Ting Li; Yun Su; Yuping Mei; Qixin Leng; Bingjie Leng; Zhenqiu Liu; Sanford A Stass; Feng Jiang
Journal:  Lab Invest       Date:  2009-12-14       Impact factor: 5.662

View more
  4 in total

1.  ALDH1A1 mediates resistance of diffuse large B cell lymphoma to the CHOP regimen.

Authors:  Ying-Hui Song; Mei-Zuo Zhong; Ping-Ping Gan; Ping-Yong Yi; You-Hong Tang; Yi-Ping Liu; Jin-Qiong Jiang; Li Li
Journal:  Tumour Biol       Date:  2014-10-25

Review 2.  Heterogeneity of tumor cells in terms of cancer-initiating cells.

Authors:  Eiichi Morii
Journal:  J Toxicol Pathol       Date:  2016-09-25       Impact factor: 1.628

3.  Effect of chemotherapy on cancer stem cells and tumor-associated macrophages in a prospective study of preoperative chemotherapy in soft tissue sarcoma.

Authors:  Keith M Skubitz; Jon D Wilson; Edward Y Cheng; Bruce R Lindgren; Kristin L M Boylan; Amy P N Skubitz
Journal:  J Transl Med       Date:  2019-04-18       Impact factor: 5.531

4.  Cancer Stem Cells of Diffuse Large B Cell Lymphoma Are Not Enriched in the CD45+CD19- cells but in the ALDHhigh Cells.

Authors:  Shupeng Song; Yongguo Li; Kaili Zhang; Xi Zhang; Yanxin Huang; Mingyan Xu; Shuangxing Li; Xue Guan; Tao Yang; Zhiyu Liu; Jie Jiang; Yunping Luo; Yinghua Lan
Journal:  J Cancer       Date:  2020-01-01       Impact factor: 4.207

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.